Mounjaro dosing: every step on the FDA label, and what each dose costs
Starting dose
- Start 2.5 mg once weekly.
The recommended starting dosage of MOUNJARO is 2.5 mg injected subcutaneously once weekly [see Dosage and Administration (2.2)].
dailymed.nlm.nih.gov, Sep 27, 2026
Stepping up
- Increase in 2.5 mg steps after at least 4 weeks if more glycemic control needed.
If additional glycemic control is needed, increase the dosage in 2.5 mg increments after at least 4 weeks on the current dose.
dailymed.nlm.nih.gov, Sep 27, 2026
Maintenance and maximum dose
- Maximum 15 mg weekly (adults).
15 mg injected subcutaneously once weekly in adults.
dailymed.nlm.nih.gov, Sep 27, 2026 - Maximum 10 mg weekly (pediatric).
10 mg injected subcutaneously once weekly in pediatric patients.
dailymed.nlm.nih.gov, Sep 27, 2026
If you miss a dose
- Missed dose: take within 4 days (96 h); otherwise skip and resume.
If a dose is missed, instruct patients to administer MOUNJARO as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.
dailymed.nlm.nih.gov, Sep 27, 2026 - Dosing day can change if doses are at least 3 days (72 h) apart.
The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours).
dailymed.nlm.nih.gov, Sep 27, 2026
How it comes
- Single-dose pen or vial strengths.
Single-dose pen or single-dose vial: 2.5 mg/0.5 mL, 5 mg/0.5 mL, 7.5 mg/0.5 mL, 10 mg/0.5 mL, 12.5 mg/0.5 mL, or 15 mg/0.5 mL (3)
dailymed.nlm.nih.gov, Sep 27, 2026 - Multi-dose vial / KwikPen: four doses each.
Multi-dose vial or single-patient-use KwikPen®: 10 mg/2.4 mL (4.17 mg/mL) for four 2.5 mg/0.6 mL doses, 20 mg/2.4 mL (8.33 mg/mL) for four 5 mg/0.6 mL doses, 30 mg/2.4 mL (12.5 mg/mL) for four 7.5 mg/0.6 mL doses, 40 mg/2.4 mL (16.7 mg/mL) for four 10 mg/0.6 mL doses, 50 mg/2.4 mL (20.8 mg/mL) for four 12.5 mg/0.6 mL doses, or 60 mg/2.4 mL (25 mg/mL) for four 15 mg/0.6 mL (3)
dailymed.nlm.nih.gov, Sep 27, 2026 - Carton configurations.
MOUNJARO is a clear, colorless to slightly yellow solution available in cartons containing 4 pre-filled single-dose pens, 1 single-dose vial, 1 multi-dose vial, or 1 Single-Patient-Use KwikPen as follows:
dailymed.nlm.nih.gov, Sep 27, 2026 - KwikPen with four 2.5 mg doses (strength and NDC).
4 doses of 2.5 mg 10 mg/2.4 mL (4.17 mg/mL) 0002-3466-11
dailymed.nlm.nih.gov, Sep 27, 2026 - KwikPen with four 5 mg doses (strength and NDC).
4 doses of 5 mg 20 mg/2.4 mL (8.33 mg/mL) 0002-3455-11
dailymed.nlm.nih.gov, Sep 27, 2026 - KwikPen with four 7.5 mg doses (strength and NDC).
4 doses of 7.5 mg 30 mg/2.4 mL (12.5 mg/mL) 0002-3444-11
dailymed.nlm.nih.gov, Sep 27, 2026 - KwikPen with four 10 mg doses (strength and NDC).
4 doses of 10 mg 40 mg/2.4 mL (16.7 mg/mL) 0002-3433-11
dailymed.nlm.nih.gov, Sep 27, 2026 - KwikPen with four 12.5 mg doses (strength and NDC).
4 doses of 12.5 mg 50 mg/2.4 mL (20.8 mg/mL) 0002-3422-11
dailymed.nlm.nih.gov, Sep 27, 2026 - KwikPen with four 15 mg doses (strength and NDC).
4 doses of 15 mg 60 mg/2.4 mL (25 mg/mL) 0002-3411-11
dailymed.nlm.nih.gov, Sep 27, 2026
Label revised 8/2026: full label on DailyMed.
What each dose costs, self-pay
52-week totals and every place to buy it: Mounjaro cost.
Your prescriber decides your dose; this page reports the label. Medical disclaimer.